Journal News

More than skin-deep

Novel bacterial lipase structure may lead to new acne treatments
Nathalie Gerassimov
June 2, 2020

Acne can have an enormous social and emotional effect on the 85% of adolescents and 40% of adults who have it. Hyo Jung Kim and colleagues in the Republic of Korea recently published a paper in the Journal of Lipid Research describing the molecular structure of a key enzyme involved in the skin disorder. This research has the potential to pave a path for new acne treatments.

The top two skin layers are the epidermis, forming the waterproof barrier, and the dermis, consisting of hair follicles and sweat glands surrounded by connective tissue. In the dermis next to hair follicles are sebaceous glands that secret sebum, a complex mixture of lipids including triglycerides and their derivatives. Acne is chronic inflammation of the sebaceous follicles, resulting in skin elevations such as papules, pustules and cysts that can lead to scarring.

Research into causes of acne focuses on Cutibacterium acnes, a Gram-positive bacterium typically found on healthy human skin, where it helps block pathogens. Specifically, C. acnes secretes lipases that break down lipids in the sebum and release fatty acids that form a protective layer on the skin surface. However, C. acnes colonization of inflamed sebaceous follicles contributes in an as-yet-unknown wayto the development of acne.

Recent research supports the idea that acne is caused by imbalances in the C. acnes subtypes and their respective lipases. Specifically, C. acnestype I subclass, called IA, is associated strongly with acne and displays higher lipase secretion and activity than C. acnes type II, which is associated with healthy skin. Excessive production of fatty acids can promote inflammation, so differences in lipase secretion and activity could be a major driver in acne development.

Acne-657x299.jpg
Ae-Ran Kwon & Hyo Jung Kim
Acne research focuses on strains and types of Cutibacterium acnes and their lipase secretion and activity. South Korean
researchers solved the structure of a highly conserved C. acnes lipase. The image shows an active site gating mechanism
involving the formation of a lid by two key phenylalanines.

In this study, the investigators solved the structures of C.acnes type II lipase by X-ray crystallography in three states: closed, blocked and open. Corresponding author Ae-Ran Kwon explained the research strategy: “The structures solved by X-ray crystallography are often compared to still images. Once you combine several images together you can extract information analogous to a moving animation, so you can see how the protein works.”

Specifically, the researchers found a novel active site gating mechanism, with two key phenylalanine residues forming a lid on top of the active site that controls lipase activity. Since this lipase is highly conserved across C.acnessubtypes, this research also applies to the acne-associated IA.

Acne treatments such as benzoyl peroxide, retinoid and antibiotics focus only on symptoms and can have undesirable side effects. Kwon, Kim and colleagues at Daegu Haany University and Woosuk University are working to design compounds that selectively block this lipase.

“Since the lipase is secreted protein, this can be a good target for topical treatment,” Kim said. “We can limit the application area to a local site of infection.”

Kim recalled suffering from mild acne breakouts when she felt stressed as a teen. “I would get so self-conscious, lose confidence in face-to-face conversation and even postpone my dates,” she said. She is confident about the high market demand for improved acne treatments.

 

 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Nathalie Gerassimov

Nathalie Gerassimov is a postdoctoral researcher at the Carnegie Institution of Washington department of embryology.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Uncovering the mechanisms of a glycosylation disorder
Journal News

Uncovering the mechanisms of a glycosylation disorder

March 27, 2026

Mutations in OGT, an enzyme that adds sugars to proteins, cause a rare neurological disorder. Using proteomics, researchers reveal how OGT interactions with TET proteins may trigger epigenetic changes and early neural defects.

Heat shock proteins as a promising breast cancer therapeutic
Journal News

Heat shock proteins as a promising breast cancer therapeutic

March 25, 2026

Researchers unveiled isoform-specific targets on heat shock protein 90 which may be beneficial in therapeutic development.

Optimized proteomic analysis of preserved biological tissue samples
Journal News

Optimized proteomic analysis of preserved biological tissue samples

March 25, 2026

Researchers have developed an optimized workflow for analyzing formalin-fixed paraffin-embedded tissue. This workflow provides an enhanced collection of unique proteins and phosphorylation sites for more detailed analysis of biological samples.

Blood proteomics reveals fungal infection signatures for faster diagnosis
Journal News

Blood proteomics reveals fungal infection signatures for faster diagnosis

March 24, 2026

Whole-blood proteomics identifies more than 3,000 host and 160 fungal proteins during cryptococcal infection, offering potential biomarkers for faster diagnosis and improved monitoring without invasive spinal taps.

When things get SAPpy: Novel insights into complement
Journal News

When things get SAPpy: Novel insights into complement

March 20, 2026

Researchers have defined interactions between an innate immune protein and two of its known binding partners. They identified potential areas of crosstalk between the two binding interactions.

Glutathione pathway implicated in rare disease
Journal News

Glutathione pathway implicated in rare disease

March 19, 2026

Researchers found that glutathione metabolism plays a central role in the pathogenesis of rare disease methylmalonic aciduria using a novel multiomics approach.